Acasti Pharma Stock Price, News & Analysis
Company Description
Acasti Pharma (NASDAQ: ACST) is a publicly traded medicinal and botanical manufacturing company in the Pharmaceutical Preparations sector. The company has a market capitalization of $34.2M, ranking #5,842 among all listed U.S. companies by market cap.
ACST stock has gained 42.2% over the past year. Shares last traded at $3.41.
This page provides a comprehensive overview of ACST stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Acasti Pharma (ACST) stock last traded at $3.41. Over the past 12 months, the stock has gained 42.2%. At a market capitalization of $34.2M, ACST is classified as a micro-cap stock with approximately 10.1M shares outstanding.
Latest News
Acasti Pharma has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 7 with negative movement. Key topics include clinical trial, conferences, earnings. View all ACST news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ACST Company Profile & Sector Positioning
Acasti Pharma (ACST) operates in the Medicinal and Botanical Manufacturing industry within the broader Pharmaceutical Preparations sector and is listed on the NASDAQ.